UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Range Financial Group LLC

Range Financial Group LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 558 shares of the healthcare conglomerate’s stock after acquiring an additional 26 shares during the period. Range Financial Group LLC’s holdings in UnitedHealth Group were worth $294,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Sugarloaf Wealth Management LLC increased its stake in shares of UnitedHealth Group by 2.4% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 5,922 shares of the healthcare conglomerate’s stock valued at $3,118,000 after acquiring an additional 139 shares during the period. Wayfinding Financial LLC increased its stake in shares of UnitedHealth Group by 21.7% during the fourth quarter. Wayfinding Financial LLC now owns 813 shares of the healthcare conglomerate’s stock valued at $428,000 after acquiring an additional 145 shares during the period. Sound Income Strategies LLC increased its stake in shares of UnitedHealth Group by 17.0% during the fourth quarter. Sound Income Strategies LLC now owns 1,443 shares of the healthcare conglomerate’s stock valued at $759,000 after acquiring an additional 210 shares during the period. Dfpg Investments LLC grew its position in UnitedHealth Group by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 10,656 shares of the healthcare conglomerate’s stock worth $5,776,000 after buying an additional 180 shares during the last quarter. Finally, Charles Schwab Trust Co grew its position in UnitedHealth Group by 17.7% in the fourth quarter. Charles Schwab Trust Co now owns 2,772 shares of the healthcare conglomerate’s stock worth $1,460,000 after buying an additional 416 shares during the last quarter. Institutional investors own 85.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Oppenheimer reiterated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens reiterated an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. HSBC reiterated a “reduce” rating and set a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $579.33.

Read Our Latest Analysis on UnitedHealth Group

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $487.08 on Tuesday. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $449.05 billion, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.34 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The firm’s 50-day moving average price is $508.35 and its two-hundred day moving average price is $518.29.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same period in the prior year, the business earned $5.34 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.79 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th will be paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.54%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s payout ratio is presently 31.54%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.